Seoul, Korea, July 14, 2025 (GLOBE NEWSWIRE) -- Top Win International Limited (Nasdaq: SORA) has partnered with Simon Gerovich (CEO of Metaplanet) and KCGI, a leading Korea-based investment firm, for a planned investment in SGA Co., Ltd. (KOSDAQ:049470). SGA Co., Ltd., has filed with the regulators disclosing that its board of directors has approved a third-party share issuance to the said consortium of investors.

The SPAC merger of Ares Acquisition Corporation II and Kodiak Robotics could bring an intriguing autonomous trucking play to market. Kodiak's partnerships with Atlas Energy Solutions and a U.S. Army contract validate the technology; aggressive negotiations into the merger agreement also provide some confidence. De-SPACs are always high-risk and usually poor-performing, and this nascent industry leaves investors guessing.

CAMAS, Wash.--(BUSINESS WIRE)--nLIGHT, Inc. (Nasdaq: LASR), a leading provider of high-power lasers for mission critical directed energy, optical sensing, and advanced manufacturing applications, today announced that it will release its financial results for the second quarter of 2025 after the financial markets close on Thursday, August 7, 2025. A conference call and simultaneous webcast to discuss the second quarter results will be held on Thursday, August 7, 2025, at 2:00 p.m. Pacific Time (.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Monogram Technologies Inc. (NASDAQ: MGRM) to Zimmer Biomet Holdings, Inc. is fair to Monogram shareholders. Under the terms of the proposed transaction, Monogram shareholders would receive an upfront payment of $4.04 per share in cash, and a non-tradeable contingent value right entitling the holder to receive up to $12.37 per share of common stock in cash if certain product development.

Key Points in This Article: Palantir Technologies (PLTR) 419% stock surge over the pat year, driven by government contract wins and an expanding enterprise client base, supports buying despite PLTR stock depite Cathie Wood selling $185 million worth of shares.

Industrial supplier Fastenal (FAST) posted a solid earnings report early Monday, opening a busy week of earnings set to be dominated by big banks and tech giants like Netflix (NFLX),

I recommend overweighting the technology sector beyond the S&P500, using diversified funds like XLK and/or QQQ for additional tech exposure. XLK's portfolio is dominated by industry leaders like Nvidia and Microsoft, both of which generate strong and growing free cash flow and are directly benefiting from the AI bull market. Leading U.S. tech companies have strong global brands and will directly benefit from the weak U.S. dollar (-9.8% YTD) when their foreign revenue is repatriated into U.S. currency.

Analyst Coverage by Cenorium Includes $22.30 Price Target Denver, Colorado--(Newsfile Corp. - July 14, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, is excited to announce that Cenorium has initiated analyst coverage of Venu Holding Corporation (NYSE American: VENU) ("Venu"). The report grants Venu Holdings a strong buy rating and set price target of $22.30 per share by 2026, reflecting significant growth potential.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Waters Corporation (NYSE: WAT) and BD and Company's Biosciences & Diagnostic Solutions business is fair to Waters shareholders. Upon completion of the proposed transaction, existing Waters shareholders are expected to own approximately 60.8% of the combined company. Halper Sadeh encourages Waters shareholders to click here to learn more about their legal rights and options or con.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Sonnet BioTherapeutics, Inc. (NASDAQ: SONN) and Rorschach I LLC is fair to Sonnet shareholders. Upon completion of the proposed transaction, Sonnet shareholders will own approximately 1% of the combined company. Halper Sadeh encourages Sonnet shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sa.

Trump's sweeping tariff threats rattled markets, but leveraged ETFs like MSOX and ETHU soared on sector momentum.

Veritex acquisition accelerates Huntington's organic growth initiatives in high-growth Texas markets; Strong 2Q results reflect growth in loans and deposits, sustained strong revenue and profit growth, as well as continued excellent credit performance COLUMBUS, Ohio and DALLAS , July 14, 2025 /PRNewswire/ -- Huntington Bancshares Incorporated (Nasdaq: HBAN), a top ten regional bank holding company headquartered in Columbus, Ohio, and Veritex Holdings, Inc. (Nasdaq: VBTX), a bank holding company headquartered in Dallas, Texas, today announced entry into a definitive merger agreement, and Huntington announced preliminary second quarter results. This strategic acquisition accelerates Huntington's strong organic growth in Texas by expanding …

SAN DIEGO , July 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit for certain investors in shares of Apple Inc. (NASDAQ: AAPL). Investors who purchased in excess of $250,000 in shares of Apple Inc. (NASDAQ: AAPL) between June 10, 2024 and June 9, 2025, have certain options and there are short and strict deadlines running.

AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a company operating at the convergence of TechBio and biological intelligence, today announced that it has received formal notification from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), concerning the minimum bid price requirement. The notice, dated July 11, 2025, stated that for the 10 consecutive business days.

Curing disease, as opposed to just masking symptoms, is a big deal. CRISPR Therapeutics aims to cure by editing problem genes. So CRSP is the future of medicine! This approach can be too futuristic for many tastes. That, plus questions about CRSP's ability to scale production and make treatments affordable, have been like a cloud over the stock. But in June, CRSP picked up some big-time expressions of support from Washington (including new HHS Secretary RFK Jr.). The stock responded with a strong rally.

Calgary, Alberta--(Newsfile Corp. - July 14, 2025) - Baytex Energy Corp. (TSX: BTE) (NYSE: BTE) ("Baytex") today announced it obtained an exemption order from the Canadian securities regulators which permits Baytex to purchase up to 10 percent of the "public float" (within the meaning of the rules of the Toronto Stock Exchange (the "TSX")) of its common shares through the New York Stock Exchange and other U.S.-based trading systems as part of Baytex's shareholder return strategy, including the current normal course issuer bid announced on June 24, 2025 (the "Current Bid"). Absent this exemptive relief, Baytex's purchases under a normal …

"The Critical Minerals and ZEO Company" ~ Antimony, Cobalt, Tungsten, and Zeolite ~ DALLAS, TX / ACCESS Newswire / July 14, 2025 / United States Antimony Corporation ("USAC," "US Antimony," or the "Company"), (NYSE:UAMY)(NYSE Texas:UAMY), provided today an update on its various procurement efforts of antimony supply necessary as feedstock for its two operating smelters located in Thompson Falls, Montana and Coahuila, Mexico ("Madero") https://www.usantimony.com/. Each region is broken out separately in alphabetical order with an explanation on each below: Alaska USAC has continued to expand its Company owned leasehold acreage position in the State of Alaska with approximately 23,800 …

bGen was selected as the thermal energy storage system for a large-scale solar energy project led by a top European utility company Marks the second bGen project within two months selected to receive European Union non-dilutive project funding 5 MWe bGen expected to contribute to the avoidance of 1.45 M tons of CO2 equivalent over 10 years and a 104% increase in energy efficiency Project configuration enables effective replacement of fossil-fuel-based steam generation in industrial processes ROSH HAAYIN, ISRAEL / ACCESS Newswire / July 14, 2025 / Brenmiller Energy Ltd. (Nasdaq:BNRG), (the "Company", "Brenmiller" or "Brenmiller Energy") a leading global …

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC and BOSTON and EMERYVILLE, Calif.

Company to Participate in Upcoming Conferences WASHINGTON , July 14, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2025 financial results on Thursday, August 7, 2025, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.